• Science & Technology

Tracing the toxic fingerprint of a bacterium in our gut 

Our Grand Challenge scientists have discovered that a common type of bacteria found in our guts could contribute to bowel cancer. Our Grand Challenge scientists have discovered that a common type of bacteria found in our guts could contribute to bowel cancer.

27 February 2020

• Health & Medicine

Genetic 'fingerprints' implicate gut bacterium in bowel cancer

Grand Challenge researchers have found that a common type of bacteria found in our guts could contribute to bowel cancer. Grand Challenge researchers have found that a common type of bacteria found in our guts could contribute to bowel cancer.

27 February 2020

• Science & Technology

The making of a living ovarian cancer biobank

Our scientists are growing a living ovarian cancer biobank in Manchester. Our scientists are growing a living ovarian cancer biobank in Manchester.

20 February 2020

• Health & Medicine

Research suggests statins could lower ovarian cancer risk

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer. A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.

18 February 2020

• Science & Technology

Zooming in on breast cancer reveals how mutations shape the tumour landscape

Scientists have created one of the most detailed maps of breast cancer ever achieved, revealing how genetic changes shape the physical tumour landscape. Scientists have created one of the most detailed maps of breast cancer ever achieved, revealing how genetic changes shape the physical tumour landscape.

17 February 2020

• Health & Medicine

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

17 February 2020

• Science & Technology

New technique allows scientists to 'listen in' on cancer cells

Scientists have a developed a new technique to decipher how millions of cells are communicating with each other in miniature tumours grown in the lab. Scientists have a developed a new technique to decipher how millions of cells are communicating with each other in miniature tumours grown in the lab.

17 February 2020

• Health & Medicine

Two skin cancer treatments get the green light for NHS Scotland

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

12 February 2020

• Health & Medicine

Targeted lung cancer treatment gets initial ‘no’ for NHS in England

Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua).  Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua). 

4 February 2020

• Health & Medicine

Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers

Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer. Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.

29 January 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

Cervical cancer progress falters as screening uptake hits record lows

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating. Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating.

22 January 2020